AE-941

· AEterna Zentaris

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AE-941, covering 2013-02-28 to 2013-02-28. Get the full timeline:

Most recent: Clinical Trial Update: AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]